Skip to main content
Premium Trial:

Request an Annual Quote

The Watchers

An Institute of Medicine report on the issues underlying the Duke University/Anil Potti research scandal has found that there are problems with the use of genetic signatures to treat or diagnose disease, reports ScienceInsider's Jocelyn Kaiser. The report says 'omics tests are "highly prone to errors," and recommends that "they be rigorously validated before being used in clinical trials," Kaiser says. "The report also calls on journals, funders, and institutions to take steps to avoid what it calls a 'failure' of oversight that allowed problems to go unchecked at Duke." IOM committee chair Gilbert Omenn, a University of Michigan biologist, tells Kaiser that what happened at Duke was caused partially by a rush to get 'omics-based tests in the clinic.

In the future, IOM says there should be a series of tests to validate 'omics diagnostics, like repeating them on blind sample sets from multiple institutions. The report also says researchers need to "lock down" their computational models before the tests get to the clinic and consult with FDA before putting a test in the clinic, Kaiser adds.

Daily Scan's sister publication, GenomeWeb Daily News, has more on the IOM report here.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.